---
figid: PMC3564524__210fig10
figlink: /pmc/articles/PMC3564524/figure/F10/
number: F10
caption: Novel signaling pathways involved in apo(a)-mediated effects on vascular
  endothelial cells. Apo(a), through its strong LBS in KIV10, binds to a putative
  receptor (possibly a complex of CD36 and TLR2), resulting in activation of a Src-
  and Rho/Rho kinase–dependent pathway to increased VE-cadherin/β-catenin complex
  dissociation, leading to an increase in vascular permeability in cultured EC. Apo(a)
  also induces a PI3K/Akt/GSK-3β signaling pathway, independent of the Rho/Rho kinase
  pathway, to increase β-catenin nuclear translocation, and hence COX-2 expression,
  and PGE2 secretion. Furthermore, apo(a) mediates loss of cell–cell contact and stimulates
  β-catenin translocation by disrupting the VE-cadherin/β-catenin complex through
  inhibition of PTEN.
pmcid: PMC3564524
papertitle: 'Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel
  pathogenic mechanism for lipoprotein(a).'
reftext: Taewoo Cho, et al. Mol Biol Cell. 2013 Feb 1;24(3):210-221.
pmc_ranked_result_index: '61332'
pathway_score: 0.8956152
filename: 210fig10.jpg
figtitle: Novel signaling pathways involved in apo(a)-mediated effects on vascular
  endothelial cells
year: '2013'
organisms: Homo sapiens
ndex: 193046ab-dee6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3564524__210fig10.html
  '@type': Dataset
  description: Novel signaling pathways involved in apo(a)-mediated effects on vascular
    endothelial cells. Apo(a), through its strong LBS in KIV10, binds to a putative
    receptor (possibly a complex of CD36 and TLR2), resulting in activation of a Src-
    and Rho/Rho kinase–dependent pathway to increased VE-cadherin/β-catenin complex
    dissociation, leading to an increase in vascular permeability in cultured EC.
    Apo(a) also induces a PI3K/Akt/GSK-3β signaling pathway, independent of the Rho/Rho
    kinase pathway, to increase β-catenin nuclear translocation, and hence COX-2 expression,
    and PGE2 secretion. Furthermore, apo(a) mediates loss of cell–cell contact and
    stimulates β-catenin translocation by disrupting the VE-cadherin/β-catenin complex
    through inhibition of PTEN.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - PIK3CD
  - PIK3R3
  - PIK3CA
  - AKT1
  - AKT2
  - PIK3R4
  - APOA5
  - PTEN
  - PIK3R5
  - APOA2
  - SRC
  - GRK1
  - PIK3CG
  - PIK3CB
  - LPA
  - CD36
  - PIK3R6
  - APOA1
  - RHOD
  - CTNNB1
  - CDH5
  - GSK3B
  - APOA4
  - TLR2
  - Cancer
genes:
- word: Akt-
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Akt-
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt-
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Lp(a)/Apo(a).
  symbol: APOA
  source: bioentities_symbol
  hgnc_symbol: APOA5
  entrez: '116519'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Lp(a)/Apo(a).
  symbol: APOA
  source: bioentities_symbol
  hgnc_symbol: APOA2
  entrez: '336'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: Rho/RhoK
  symbol: RHOK
  source: hgnc_prev_symbol
  hgnc_symbol: GRK1
  entrez: '6011'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Lp(a)/Apo(a).
  symbol: Lp(a)
  source: hgnc_alias_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: CD36/TLR2?
  symbol: CD36
  source: hgnc_symbol
  hgnc_symbol: CD36
  entrez: '948'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Lp(a)/Apo(a).
  symbol: APOA
  source: bioentities_symbol
  hgnc_symbol: APOA1
  entrez: '335'
- word: Rho/RhoK
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: VE-Cadherin/Catenins
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Lp(a)/Apo(a).
  symbol: APOA
  source: bioentities_symbol
  hgnc_symbol: APOA4
  entrez: '337'
- word: CD36/TLR2?
  symbol: TLR2
  source: hgnc_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3564524__F10
redirect_from: /figures/PMC3564524__F10
figtype: Figure
---
